Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4GENENTECH INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 30MG/ML

Approval Date :

Application Number : 761083

RX/OTC/DISCN :

RLD :

TE Code :

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 60MG/0.4ML

Approval Date :

Application Number : 761083

RX/OTC/DISCN :

RLD :

TE Code :

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 105MG/0.7ML

Approval Date :

Application Number : 761083

RX/OTC/DISCN :

RLD :

TE Code :

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 150MG

Approval Date :

Application Number : 761083

RX/OTC/DISCN :

RLD :

TE Code :

blank